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p53 protein is an important regulatory factor involved in cell growth and development. In our pre-
vious study, we demonstrated that recombined zebraﬁsh p53 protein could speciﬁcally bind to its
own mRNA in vitro. To determine if a similar interaction exists in zebraﬁsh and if this interaction
affects zebraﬁsh development, in the present study, we investigated the interaction of p53 protein
and its mRNA in zebraﬁsh embryos. Our results revealed that expressed zebraﬁsh p53 protein could
bind with its own mRNA in zebraﬁsh embryos. Furthermore, the endogenous activated or ectopi-
cally expressed p53 protein could enhance the relative activity of Renilla luciferase fused with
p53 30UTR in response to UV irradiation and CPT treatment, and retarded development of zebraﬁsh
embryos was observed.
 2012 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction nucleolin were reported suppressing p53 translation by bindingp53 protein plays a critical role in controlling the cell cycle, cell
growth, and development [1,2]. As a central regulation factor, the
expression and stability of p53 protein is regulated at different lev-
els, including transcriptional, translational, and post-translational
regulation [3,4]. In unperturbed cells, p53 protein is normally
short-lived and maintained at low levels attributing to the rapid
proteasomal degradation [2,5,6]. While in response to cellular
stresses, such as DNA damage, hypoxia, or nutrient deprivation,
intracellular p53 protein is quickly accumulated and leads to
growth arrest of cell cycle or apoptosis [1,7]. It has been well estab-
lished that posttranslational modiﬁcation, such as phosphoryla-
tion, acetylation, and altered intracellular localization, plays an
important role in the rapid accumulation of p53 protein in re-
sponse to cellular stresses. For example, phosphorylation increases
the stability of p53 protein, which reduces the degradation of p53
protein by its negative regulation protein mdm2 and hence results
in the elevation of p53 protein level in cells [2,5,6]. Increasing doc-
uments have suggested that translational control of p53 mRNA is
another crucial reason accounting for the elevation of p53 protein
in response to stresses [8,9]. For example, HuR and RPL26 protein
have been reported to enhance p53 translation by binding with
the 30UTR or 50UTR of p53 mRNA [4,9]. Thymidylate synthase andchemical Societies. Published by E
Chinese Academy of Sciences,to the coding sequence and 50UTR of p53 mRNA respectively
[4,8]. Furthermore, p53 protein of murine and human could nega-
tively regulate its own mRNA translation by direct binding with
the 50UTR or 30UTR of its cognate mRNA [10].
The zebraﬁsh, Danio rerio, is an ideal model organism for study-
ing developmental biology due to its unique characteristics,
including high fecundity, short reproductive cycle, external fertil-
ization, and transparency that permits visual assessment of devel-
oping cells and organs [11–15]. Studies have shown that p53 plays
pivotal roles in the development of zebraﬁsh embryos [16]. Main-
taining the appropriate level of p53 protein is important for zebra-
ﬁsh development. Stresses such as a short exposure to UV
irradiation or treatment with camptothecin (CPT) can activate
p53 protein and result in growth retardation in zebraﬁsh embryos
[6]. Knockdown of mdm2, the most important negative regulation
factor of p53 protein, results in severe apoptosis and retardation of
development [6]. However, little is known about the translation
regulation of p53 in zebraﬁsh embryos.
In our previous study, we expressed zebraﬁsh p53 protein using
prokaryotic expression system, and have demonstrated that recom-
bined zebraﬁsh p53 protein can specially bind to its own mRNA
in vitro as evidenced by immunoprecipitation: RT-PCR analysis
and a UV-crosslinking experiment [17]. However, little is known
about the function of the interaction between mRNA and proteins
in zebraﬁsh, and the effect of this interaction on zebraﬁsh develop-
ment need to be addressed. In the present study, the interaction oflsevier B.V. All rights reserved.
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the effect of this interaction on development of zebraﬁsh embryos
was also investigated. Our results revealed that p53 protein could
bind with the endogenous p53 mRNA in zebraﬁsh embryos and
the interaction between zebraﬁsh p53 protein and its cognate
mRNA could enhance the translational efﬁciency of p53 protein in
response to UV irradiation and CPT treatment. Moreover, retarded
development of zebraﬁsh embryos was also observed.
2. Materials and methods
2.1. In vitro transcription of full-length p53, p53 50UTR+ORF and p53
30UTR mRNA
The full- length p53 gene (including the 50UTR and 30UTR), p53
50UTR+ORF and p53 30UTR was obtained by PCR ampliﬁcation
using the following speciﬁc primers:
full-length p53(forward): 50-TAATACGACTCACTATAGGGGTTTAGT
GGAGAGGAGGTCG -30,
full-length p53(reverse): 50-AAAGAGTGTATTTTAAAACATTTCTC-30;
p5350UTR+ORF(forward): 50-TAATACGACTCACTATAGGGGTTTAG T
GGAGAGGAGGTCG -30,
p5350UTR+ORF(reverse): 50-TTAATGATGATGATGATGATGATCAGA
GTCGCTTCTTCCTTC-30;
p53-30UTR(forward):50-TAATACGACTCACTATAGGGGCGACTCTGAT
TAAGGTGATGGGATG-30,
p53-30UTR(reverse):50-AAAGAGTGTGTATTTTAAAACATTTCTC-30.
The 50 end of forward primer contains a T7 promoter (in bold)
that permits transcription in vitro by T7 RNA polymerase. The
PCR products were resolved on 1% agarose gel, puriﬁed using the
Gel Recovery Kit (Tiangen, China), and used as templates for the
synthesis of corresponding RNAs. Biotin-labeled RNAs were syn-
thesized using the MEGAscript transcription kit (Ambion, CA) [17].
2.2. UV-crosslinking
Biotin-labeled full-length p53, p53 50UTR+ORF and p53 30UTR
mRNA were obtained through transcription in vitro as described
above. recombinant p53 protein was prepared as described in our
previous report[17]. RNA–protein binding reaction mixtures
(20 ll), containing 100 ng of biotin-labeled full- length p53, p53
50UTR+ORF or p53 30UTRmRNA and 1 lg of recombinant renatured
p53 protein, were incubated at room temperature for 30 min and
then cross-linked by UV irradiation for 15 min at 254 nm [18].
The mixtures were digested with RNaseA1 (1 mg/ml) at 37 C for
30 min and resolved on 12% SDS–PAGE. The gel was electroblotted
onto a Plus Positively Charged Nylon Membrane (Ambion, CA), and
then the membrane was irradiated by UV irradiation to immobilize
the RNA probe onto the membrane. The BrightStar BioDetect™ Kit
(Ambion, CA) was used to detect the binding complex following
the manufacturer0s protocol. In brief, the membrane was washed
two times for 5 min each time using washing buffer and then incu-
bated in blocking buffer for 30 min. Streptavidin–alkaline phospha-
tase buffer (1:10,000)was added and themembranewas allowed to
incubate for 30 min, followed bywashing three times with washing
buffer. CDP-Star was used as chemiluminescent substrate for detec-
tion of alkaline phosphatase to visualize the protein–RNA complex.2.3. Synthesis of zebraﬁsh p53 expression constructs and luciferase
report vectors
The isolated total RNA from Zebraﬁsh embryos was reverse
transcribed into cDNA using M-MLV reverse transcriptase (Takara,
Japan) [11]. The open reading frame (ORF) and the 30 untranslatedregion (UTR) of zebraﬁsh p53 were ampliﬁed by PCR using the fol-
lowing primers respectively:
p53-ORF(forward):50-GGATCCATGGCGCAAAACGACAGCCAAG-30,
p53-ORF(reverse):50-GAATTCTTAATGATGATGATGATGATGATCAG
AGTCGCTTCTTCCTTC-30
p53-30UTR(forward): 50- CTCGAGGCGACTCTGATTAAGGTGATGG-
GATG-30,
p53-30UTR(reverse):50-GCGGCCGCAAAGAGTGTGTATTTTAAAA-
CATTTCTC-30
For the convenience of detection, a His-tag sequence, which is
indicated by italic in the p53-ORF reverse primer, was introduced
into the C- terminus of recombined p53 protein just before the stop
codon.
The PCR products of p53 ORF and 30UTR were inserted into
pMD-18T cloning vectors (Takara, Japan). After sequencing, p53
ORF was sub-cloned into the corresponding sites of BamHI and
EcoRI on the eukaryotic expression pcDNA3.1 vector (Fig. 1A). psi-
CHECK-2(Promega, WI)), which contains both Renilla and ﬁreﬂy
luciferase reporter genes, enable the monitoring of changes in
expression of a target gene fused to the reporter gene (Renilla lucif-
erase). The ﬁreﬂy reporter cassette has been speciﬁcally designed
to be an intraplasmid transfection normalization reporter. The
30UTR of p53 was ligated into the psiCHECK-2 vector, between
the XhoI and NotI sites, immediately downstream of the Renilla
luciferase gene (Fig 1C). The construct of pcDNA3.1/his-TS
(thymidylate synthase) was constructed previously by our labora-
tory (Fig 1D) [11] .
2.4. Culture of zebraﬁsh embryos and manipulation of microinjection
and UV irradiation
Zebraﬁsh were maintained on a 14–10 h light dark cycle at
28 C according to standard laboratory conditions of Kimmel
[19]. The embryos at 1–2 cells stage were obtained by natural
crossing. The linearized plasmids (100 pg) of Luciferase report con-
structs psiCHECK/p53 30UTR were microinjected alone or co-
microinjected with pcDNA3.1/his-p53 into embryos at 1–2 cell
stage, and then the embryos were transferred to a 6-well plate
and raised in embryo medium at 28 C [20,21]. The UV irradiation
experiment was performed as described by Mazan-Mamczarz [9].
Brieﬂy, plasmids were microinjected into the embryos at 1–2 cell
stage. After cultured for 12 h, the medium was removed, and em-
bryo cells were washed with PBS and irradiated with 15 J/m2
UVC for 4 h and fresh medium was supplemented.
2.5. Western immunoblot analysis
Zebraﬁsh embryos were microinjected without or with
pcDNA3.1/his-p53 plasmids. After cultured for 48 h, the zebraﬁsh
embryos were harvested by centrifugation at 1000g. Zebraﬁsh
embryos homogenate were prepared using ice-cold RIPA buffer
(50 mM Tris–HCl, 1% NP40, 0.25% Na-doxycholate. 150 mM NaCl,
1 mM EDTA) which contains PMSF at a ﬁnal concentration of
1 nm/mL. Protein concentrations were determined using BCA pro-
tein assay kit (Thermo Scientiﬁc, FL). Immunoblot analysis was
performed as previously described [11]. Brieﬂy, whole-cell lysates
were resolved by 12% SDS–PAGE and then electroblotted onto a
nitrocellulose membrane (Bio-Rad, CA). The membrane then was
incubated in blocking buffer (1 PBS, 0.1% Tween-20, and 5%
non-fat dry milk powder) for 2 h. Membrane was incubated for
1 h with primary antibodies anti-his monoclonal antibody (1:200,
Santa Cruz, CA). After three 10 min washes, membranes were incu-
bated with a dilution of 1:2000 of horseradish peroxidase-conju-
gated secondary antibody (Goat anti-mouse, BioRed) for 1 h at
room temperature. chemiluminescence method was employed to
Fig. 1. Synthesis of zebraﬁsh p53 expression vector and luciferase report vector. (A) Zebraﬁsh p53 ORF was subcloned into the corresponding sites of BamHI and EcoRI of the
eukaryotic expression pcDNA3.1 vector to construct a pcDNA3.1/his-p53 plasmid (B) psiCHECK-2 vector. (C) The 30UTR of p53 were cloned into the psiCHECK-2 vector
(Promega), between the XhoI and NotI sites, immediately downstream from the Renilla luciferase gene. (D) construct of pcDNA3.1/his-TS.
1222 X. Zhao et al. / FEBS Letters 586 (2012) 1220–1225detect the signals using Super Signal West Dura (Thermo Scientiﬁc,
FL) and protein bands were visualized by autoradiography.
2.6. Immunoprecipitation: RT-PCR analysis
To evaluate the interaction between p53 protein and its mRNA
in zebraﬁsh embryos, immunoprecipitation (IP):RT-PCR analysis
was performed as described previously [9,22]. pcDNA3.1/his-p53
and pcDNA3.1/his-TS were microinjected into zeraﬁsh embryos as
described above. After cultured for 48 h, the embryo cells were har-
vested and washed with ice-cold phosphate-buffered saline (PBS)
and lysed in buffer B (containing 50 mM Tris–HCl (pH 8), 150 mM
NaCl, 1% NP-40) along with protease inhibitor cocktail. Total cell ly-
sates were incubated with anti-his monoclonal antibody (Santa
Cruz, CA) for 4 h followed by protein A/G-Sepharose (Amersham
Bioscience) for additional 1 h treatment at 4 C. The precipitated
pellet was collected by centrifugation at 3000g for 10 min, and
subjected to phenol/chloroform extraction. The RNA isolated from
the complex was subjected to RT-PCR to detect the presence of
p53 mRNA. The p53-30UTR was ampliﬁed by using the primer pairs
described above. PCR products were resolved using 1.5% agarose
gels, and visualized by ethidium bromide staining.
2.7. Luciferase reporter assay
psiCHECK/p53 30UTR luciferase reporter construct along or
combined with pcDNA3.1/his-p53 was microinjected into zebra-
ﬁsh embryos at 1–2 cells stage. After cultured for 12 h, CPT
(200 nM) was added to the medium and cultured for another
12 h, UV irradiation experiment was performed as described above,
and then the cells were harvested at indicated time by centrifuga-
tion at 1000g for 10 min and lysed using lysis buffer. Fireﬂy and
Renilla luciferase activities were measured by using the Dual-
Luciferase reporter assay system (Promega, WI) following the man-
ufacturer’s protocol. The relative activity data of Renilla luciferase
are normalized to the internal ﬁreﬂy luciferase.
2.8. Real time PCR
Real-time PCR was performed to detect the expression of Renil-
la luciferase mRNA and p53 30UTR mRNA using an ABI7300 System
(Bio-Red, USA). The results were recorded as threshold cycle
numbers (Ct), which were normalized against an internal control
(b-actin mRNA) using the 2(-Delta Delta C (T) Method. Ampliﬁca-
tion condition is as follows:95 C 30 s ; 95 C 5 s,60 C 31 s, for 40
cycles.2.9. Morphological observation of zebraﬁsh embryos
psiCHECK/p53 30UTR luciferase reporter construct along or
combined with pcDNA3.1/his-p53 were microinjected into
zebraﬁsh embryos at 1–2 cells stage. After cultured for 12 h, the
zebraﬁsh embryos were subjected to CPT treatment for 12 h or
UV irradiation for 4 h. The developmental alterations of zebraﬁsh
embryos were visualized under the CKX41 phase contrast micros-
copy (Olympus, Japan) and photographed at 72 h after fertilization.
3. Results
The binding site of recombined zebraﬁsh p53 protein on its
mRNA was identiﬁed by UV cross-linking experiment in vitro.
Full-length (Fig. 2A, lane 1) or 30UTR region of p53 mRNA
(Fig. 2A, lane 2) could interact with p53 protein speciﬁcally. In con-
trast, after deleting the 30UTR of p53 mRNA, the remaining coding
region could not interact with p53 protein (Fig. 2A, lane 3). This re-
sult suggested that p53 protein could interact with the 30UTR re-
gion of p53 mRNA speciﬁcally.
To evaluate the interaction between p53 protein and its own
mRNA in zebraﬁsh embryos, the eukaryotic expression vector
pcDNA3.1/his-p53 was constructed (Fig. 1A) and microinjected
into zebraﬁsh embryos. The ectopic expressed p53 protein was
determined by Western blot analysis. As shown in Fig. 2B, recom-
bined p53 protein could be successfully expressed in zebraﬁsh em-
bryos. Next, an immunoprecipitation: RT-PCR experiment was
performed to assess the association of ectopic expressed p53 pro-
tein with endogenous p53 mRNA. After microinjection of
pcDNA3.1/his-p53 or pcDNA3.1/his-TS, total lysates of zbraﬁsh
embryos were extracted and incubated with anti-his monoclonal
antibody, and then followed by protein A/G-Sepharose incubation.
The p53-mRNA complex absorbed on the protein A-agarose was
extracted using phenol/chloroform. After ampliﬁcation by RT-
PCR, p53 mRNA was dramatically enriched and was ampliﬁed from
the complex and visualized by ethidium bromide staining (Fig. 2C,
lane 2, 4). The results revealed that an interaction between his-p53
protein and its own mRNA exists in zebraﬁsh embryos.
We next studied the interaction of the p53 protein and its own
mRNA on p53 mRNA translation in response to UV irradiation or
CPT treatment. The psiCHECK/p53 30UTR was microinjected or
co-microinjected with pcDNA3.1/his-p53 into zebraﬁsh embryos.
As shown in Fig 3, the luciferase activity was signiﬁcantly in-
creased in zebraﬁsh embryos, co-microinjected psiCHECK/p53
30UTR and pcDNA3.1/his-p53, compared with those only microin-
jected with psiCHECK/p53 30UTR, suggesting the ectopic expressed
Fig. 2. Interaction of p53 with its cognate mRNA in zebraﬁsh embryos. (A) UV
cross-linking was performed to detect the binding of zebraﬁsh p53 protein with its
mRNA in vitro as described in the Materials and Methods. p53 protein (1 lg) was
incubated with Biotin-labeled full- length p53mRNA (lane1), p53 30UTRmRNA(lane
2), p53 50UTR+ORF mRNA(lane 3). (B) Expression of ectopic his-p53 in zebraﬁsh
embryos. His-p53 expression was determined in zebraﬁsh embryos untreated (lane
2) or treated with pcDNA3.1/his-p53 by Western blot using anti-his antibody (lane
1). (C) Plasmid pcDNA3.1/his-p53 was microinjected into zebraﬁsh embryos as
described above, the whole cells lysate was subjected to immunoprecipitation in
the absence of his antibody replaced by ﬂag antibody (lane 1) or in the present of
his antibody (lane 2) and thymidylate synthase (lane 5). The RNA isolated from the
complex was subjected to RT-PCR to detect the presence of p53 mRNA in the
presence of reverse transcriptase (lane 4) or in the absence of reverse transcriptase
(lane 3). PCR products were visualized by ethidium bromide staining of 1.5%
agarose gels.
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Additionally, UV irradiation or CPT treatment also resulted in an
augmentation of luciferase activity in the embryos microinjected
with psiCHECK/p53 30UTR. In contrast, no signiﬁcant difference of
luciferase activity was found in embryos microinjected psi-
CHECK-2 when treated with UV or CPT. And also, ectopic expres-
sion of p53 could not affect the luciferase activity in embryos
microinjected psiCHECK-2 construct. The results suggested that
the induced expression of endogenous p53 in embryos responsive
to stress also interacts with the 30UTR region of p53 mRNA, and re-
sults in an increased expression of luciferase activity.
We then determined whether the enhancement of Renilla lucif-
erase was resulting from the translational enhancement of Renilla
luciferase mRNA. The expression of Renilla luciferase mRNA was
detected by real time PCR and the luciferase activity was
determined by Dual-Luciferase reporter assay system (Promega,
WI) respectively. As shown in Fig. 4, the relative activity of Renilla
luciferase in embryos microinjected with psiCHECK/p53 30UTR
after UV irradiation and CPT treatment was much higher than that
in the embryos untreated with UV or CPT (Fig. 4A). However, there
is no signiﬁcant difference of the mRNA levels among these groups
(Fig. 4B). The result suggested that the increased luciferase activity
in response to UV or CPT treatment resulted from an increasedFig. 3. Effects of ectopic expressed p53 protein and CPT treatment or UV irradiation o
Luciferase report constructs psiCHECK/p53 30UTR were microinjected alone or co- micro
used as control in each group. Twelve hours after microinjection, zebraﬁsh embryos t
pcDNA3/his-p53were subjected to CPT (200 nM) treatment for 12 h or UV irradiation
reporter assay system. The experiments were performed in triplicate with three indepeefﬁciency of lucifease mRNA translation. These results also re-
vealed that there is an interaction of p53 and 30UTR of p53 mRNA
and the interaction results in an increased expression of p53 in re-
sponse to stress, including UV and CPT treatments.
To study if the interaction between p53 and its own mRNA af-
fects the development of zebraﬁsh embryos, we compared the
development of different treated embryos with the normal control
embryos. As shown in Fig. 5, obvious retarded development of zeb-
raﬁsh embryos were found in embryos treated with CPT or UV. The
development was also affected in embryos co-microinjected with
psiCHECK/p53 30UTR and pcDNA3.1/his-p53. More severe develop-
mental retardation was observed in the group co-microinjected
with psiCHECK/p53 30UTR and pcDNA3.1/his-p53 after CPT or UV
treatment. We found that the retardation of development occurred
in several organs, including abdominal swelling, heart weakness
and the deformity of the tail. In addition, we also observed that
the blood ﬂow of the retarded embryos obviously slowed down.
This result suggested that the interaction of p53 with its own
mRNA results in retarded development zebraﬁsh embryos.
4. Discussion
In the present study, we ﬁrst conﬁrmed there is interaction of
p53 with its own mRNA in zebraﬁsh embryos. Further study
showed that the interaction could enhance translational efﬁciency
of p53 mRNA. In response to DNA damage such as UV irradiation or
CPT treatment, the increased expression of p53 could increase the
binding ability of p53 with its cognate mRNA.
p53 protein family is an important teratologic suppressor, but
in certain conditions it can cause congenital abnormalities [16].
Maintaining appropriate level of p53 protein is pivotal for zebraﬁsh
normal development. All factors involved in p53 production and
functionmay affect embryonic development of zebraﬁsh. Activated
and increased accumulated p53 protein could activate p53-depen-
dent checkpoint to prevent improper embryonic development,
resulting in growth retardation in zebraﬁsh embryos [6,23]. For
example, Knockdown of mdm2, the most important negative regu-
lation factor of p53 protein, results in severe apoptosis and retarda-
tion of development [6], Ribosome L11 could bind with mdm2 and
abrogate the mdm2-induced p53 degradation in response to ribo-
somal stress. The Ribosome L11-deﬁcient embryos also displayed
developmental abnormalities and embryonic lethality [23]. So, to
some extent, up-regulation of p53 may cause negative impact on
zebraﬁsh embryonic development. In the present study, the results
showed that the interaction of p53 with its own RNA increasedn the relative activity of Renilla luciferase. The linearizated plasmids (100 pg) of
injected with pcDNA3/his-p53 into 1–2 cell stage embryos. psiCHECK-2 vector was
hat were microinjected with psiCHECK/p53 30UTR alone or co-microinjected with
for 4 h. Then the relative luciferase activity was measured using Dual-Luciferase
ndent experiments. ⁄⁄P < 0.01, as compared to psiCHECK-2 control group.
Fig. 4. p53 protein enhanced translation efﬁciency of Renilla luciferase mRNA without changing the mRNA level. (A) The Luciferase report construct psiCHECK/p53 30UTR
were microinjected into 1–2 cell stage embryos as described above. The relative luciferase activity was measured using Dual-Luciferase reporter assay system at indicated
time (0, 6,12,24,48 h) after CPT treatment for 12 h or UV irradiation for 4 h. (B) The mRNA expression level of luciferase at the corresponding time was detected by real-time
PCR. The relative expression of luciferase mRNA was the ratio of the expression level of to that of b-actin. The experiments were preformed more than three times. ⁄⁄P < 0.01,
as compared to psiCHECK-2 control group.
Fig. 5. The observed changes of zebraﬁsh development. The developmental alterations of zebraﬁsh embryos with different treatment were visualized under the CKX41 phase
contrast microscopy and photographed at 72 h after fertilization.
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development. In response to some stressful conditions like UV
irradiation or drug treatment, the auto-regulation mechanism
could, in some part, intensify the stressful effects of embryos
development.
Previous studies have shown that p53 was quickly accumulated
and increased translation was found in cells in response to DNA
damage such as UV irradiation or DNA damage agents [8,9]. CPT
treatment increases the p53 expression in human gastric cancer
cells [24]. Additionally, Induction of apoptosis and tissue degrada-
tion by CPT and roscovitine is also dependent on p53 expression
[6]. In irradiated cells such as MCF-7, p53 translation was en-
hanced by Ribosomal protein L26 (RPL26) through binding to its
50UTR [4]. Our present study showed that in similar conditions,
the increased expression of p53 can enhance the interaction of
p53 with its own mRNA, resulting in the augmentation of
efﬁciency of p53 mRNA translation. This ﬁnding increases our
understanding of the function of p53, especially in response to
some stressful conditions.
Translational control of p53 mRNA is an important mechanism
accounting for the elevation of p53 protein in response to stresses
[8,9]. It plays some key roles in cell proliferation, development, and
apoptosis. For example, the translational enhancement of p53 pro-
tein by RPL26 could induce G1 cell-cycle arrest, and augments irra-
diation-induced apoptosis [4]. In zebraﬁsh embryos, the loss ofribosomal protein L11, a negative regulation factor of p53, also af-
fected embryonic development via a p53-dependent apoptotic
mechanism [23]. Auto-regulation is an important model of transla-
tional regulation for proteins. The binding sites of proteins on its
own mRNA could locate on the regions of 50UTR, coding region or
30UTR [10,25]. For example, p53 protein of murine and human
could bind to the 50UTR or 30UTR on its own mRNA[10]. In the pres-
ent study, we conﬁrmed that there also exist an interaction be-
tween p53 protein and its cognate mRNA in zebraﬁsh embryos,
and the binding site is located on the 30UTR region. However, the
cis-element region localized on the 30UTR of p53 mRNA is
unknown. Study is in progress in our laboratory to address the
interaction nucleotides of p53 mRNA, this will increase our under-
standing of the auto-regulation mechanism of p53.
In the present study, we also found that similar as human
Thymidylate synthase [26], thymidylate synthase (TS) could also
bind with p53 mRNA (Fig. 2C, lane 5). More study is needed to ad-
dress if a similar mechanism occurred between TS and p53 in zeb-
raﬁsh embryos.
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